3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Stomach Neoplasms
43
Carcinoma, Hepatocellular
41
Carcinoma, Non-Small-Cell Lung
17
Colorectal Neoplasms
14
Breast Neoplasms
14
Small Cell Lung Carcinoma
12
Sarcoma
11
Ovarian Neoplasms
11
Nasopharyngeal Carcinoma
11
Triple Negative Breast Neoplasms
10
Lung Neoplasms
10
Cholangiocarcinoma
10
Esophageal Squamous Cell Carcinoma
9
Esophageal Neoplasms
9
Osteosarcoma
8
Biliary Tract Neoplasms
8
Advanced Gastric Cancer
8
Neoplasms
6
Head and Neck Neoplasms
6
Uterine Cervical Neoplasms
5
Squamous Cell Carcinoma of Head and Neck
5
Recurrence
5
Pancreatic Neoplasms
5
Neoplasm Metastasis
5
Liver Neoplasms
5
Glioma
5
Drug-Related Side Effects and Adverse Reactions
4
Thyroid Neoplasms
3
Melanoma
3
Gastrointestinal Neoplasms
3
Interventions
Rituximab
7
Valganciclovir
5
Valacyclovir
3
Gemcitabine
3
Dexamethasone
3
Cisplatin
3
spartalizumab
2
pegaspargase
2
Radiotherapy, Intensity-Modulated
2
Methylprednisolone
2
Lenalidomide
2
Etoposide
2
Doxorubicin
2
Cell Count
2
Blood Specimen Collection
2
valomaciclovir
1
toripalimab
1
ruxolitinib
1
pembrolizumab
1
merphos
1
fludarabine
1
dehydroftorafur
1
avelumab
1
apatinib
1
Zidovudine
1
Watchful Waiting
1
Valproic Acid
1
Vaccines
1
Tenofovir
1
Tegafur
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Epstein-Barr Virus Infections
×
apatinib
×
Clear all
NCT02874651
2022-01-11
ADVANCE
Sun Yat-sen University
Phase 2
Terminated
25 enrolled